ECHO Type 1 Diabetes is an 18-month pilot program, which is allowing researchers at the University of Florida and Stanford University to learn more about how to improve care access for underserved adult and pediatric communities living with Type 1 Diabetes (T1D).

UF Diabetes Institute Director: Mark Atkinson, Ph.D. The UF Diabetes Institute completed its third year in 2017, pushing forward toward its overarching mission to improve the lives of those living with diabetes so that we may one day see a diabetes-free world. With one new person diagnosed with diabetes every…

Medical News Today Article – Expert commentary by nPOD investigators. “The beauty of this approach is the virtual lack of any adverse effects, since it would use the patients’ own cells.” –Prof. Paolo Fiorina…

“We’re building the path to a future without type 1 diabetes.” TrialNet is an international network of leading academic institutions, physicians, scientists and healthcare teams dedicated to the prevention of type 1 diabetes. We offer risk screening for relatives of people with type 1 diabetes and innovative clinical…

Join the UF Diabetes Institute in recognition of National Diabetes Awareness Month and World Diabetes Day.